Press room
  • Products
  • Science
  • About
  • Investor Relations
  • Products
    • Animal HealthNutraceuticalsWebinars
  • Science
    • Our SciencePatentsScientific Reports
  • About
    • About AxichemMissionVisionJoin UsEco-friendlyHistoryBusiness model
  • Investor Relations
    • Commissioned ResearchCompany descriptionCorporate GovernanceFinancial CalendarFinancial ReportsGeneral Meetings ArchiveInvestor EnquiriesInvestor structurePress ReleasesProspectus ArchiveAnnual General Meeting 2026
axichem.se Press releases
Inbjudan att teckna aktier i aXichem AB
Back
October 14, 2009
Inbjudan att teckna aktier i aXichem AB
Back

  • Härmed inbjuds allmänheten att teckna aktier i aXichem AB
  • 4,50 SEK aktie
Back
Further reading
October 14, 2026
aXichem erhåller order för aXivite[®] värd 1,2 miljoner kronor från ett multi-level-marketing-företag i USA
October 14, 2026
aXichem receives order for aXivite[®] of SEK 1.2 million from a U.S. multi-level marketing company
September 23, 2026
aXichem AB (publ) genomför en riktad emission i samband med utnyttjande av teckningsoptioner av serie TO2A
Our Brands
back to top
 
Södergatan 26
211 34 Malmö
SWEDEN
+46 40 12 13 55

 
About
Science and R&D
Products
Investor Relations
Press Room
Join Us
Contact
Sitemap

© aXichem AB 2024